TOS-358

· Totus Medicines

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TOS-358, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer [Phase 1]